Publication Name	World Journal of Gastroenterology
Manuscript ID	10986
Country	Netherlands

Received	2014-04-29 12:33
Peer-Review Started	2014-04-29 19:04
To Make the First Decision	2014-06-10 13:19
Return for Revision	2014-06-17 16:20
Revised	2014-06-30 17:37
Second Decision	2014-07-25 09:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-07-25 09:36
Articles in Press	2014-07-25 10:02
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-10-24 09:37
Publish the Manuscript Online	2014-11-10 19:10

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Observational Study
Article Title	Performance of the Montreal classification for inflammatory bowel diseases
Manuscript Source	Unsolicited Manuscript
All Author List	Lieke M Spekhorst, Marijn C Visschedijk, Rudi Alberts, Eleonora A Festen, Egbert-Jan van der Wouden, Gerard Dijkstra and Rinse K Weersma; Dutch Initiative on Crohn and Colitis (ICC)
Funding Agency and Grant Number	Funding Agency Grant Number Netherlands Organization for Scientific Research (NWO) 016.136.308 (to Weersma RK) Netherlands Organization for Scientific Research (NWO) 92.003.577 (to Visschedijk MC) MLDS grant of the Dutch Digestive Foundation WO 11-72 (to Alberts R)
Corresponding Author	Rinse K Weersma, MD, PhD, Professor, Department of Gastroenterology and Hepatology, University of Groningen and University Medical Centre Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. r.k.weersma@umcg.nl
Key Words	Crohn’s disease; Ulcerative colitis; Montreal classification; Phenotypes- inter-observer agreement
Core Tip	According to our study, the Montreal is a reliable classification system for phenotypes in inflammatory bowel disease, except for disease severity in ulcerative colitis. The inter-observer agreement for scoring Crohn’s disease severity was moderate. This highlights the need for accurate medical reporting and the use of additional parameters to define and classify disease severity. Such alternations are necessary to ensure high-quality data in multicentre prospective data collections.
Publish Date	2014-11-10 19:10
Citation	Spekhorst LM, Visschedijk MC, Alberts R, Festen EA, van der Wouden EJ, Dijkstra G, Weersma RK; Dutch Initiative on Crohn and Colitis (ICC). Performance of the Montreal classification for inflammatory bowel diseases. World J Gastroenterol 2014; 20(41): 15374-15381
URL	http://www.wjgnet.com/1007-9327/full/v20/i41/15374.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i41.15374

Full Article (PDF)	WJG-20-15374.pdf
Full Article (Word)	WJG-20-15374.doc
Manuscript File	10986-Review.doc
Answering Reviewers	10986-Answering reviewers.pdf
Copyright License Agreement	10986-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	10986-Language certificate.pdf
Peer-review Report	10986-Peer reviews.pdf
Scientific Misconduct Check	10986-CrossCheck.jpg
Scientific Editor Work List	10986-Scientific editor work list.pdf